Safran Stock: Shares Struggle at Resistance After a 37% Surge Over a Year
Safran's stock ended the session on Friday, February 27, down 1.9% at 340 euros, after reaching a near-resistance price of 346.60 euros the day before. Nonetheless, the stock has shown a gain of over 17% in three months and nearly 37% over a year. This decline occurs in a context of profit-taking after a sustained bullish phase.
Resistance and Technical Pullback
On Friday, Safran was hindered by its proximity to the resistance threshold at 347.20 euros, a level the price failed to surpass at the close the previous day (346.60 euros). This technical pullback is accompanied by an RSI of 76, indicating that the stock is in an overbought zone — suggesting that the bullish momentum of recent weeks might temporarily weaken. However, the 50-day moving average, at 314.60 euros, remains well below the current price, confirming that the underlying trend is still oriented upwards over the medium term. The stock has lost 0.61% over the last seven days, a moderate decline that reflects a consolidation phase rather than a trend reversal. The most relevant support is at 298.60 euros, about 12% below the closing price, a gap that still offers a comfortable margin before questioning the upward trajectory that has been engaged for several months.
Key Upcoming Dates for Shareholders
The next major event for shareholders of the aerospace equipment manufacturer is scheduled for April 23, 2026, the date set for the publication of the first quarter results. This deadline will assess whether the group's commercial momentum, driven by the ramp-up of global aerospace production in recent quarters, is maintained at the same pace. The general assembly is meanwhile scheduled for May 21, followed by the publication of the half-year accounts on July 28 and the third quarter results on October 23. These milestones will mark the stock market year for the engine manufacturer and could provide catalysts that may either boost or hinder the stock's progress. With a beta of 0.01, the stock also shows a marked decorrelation from the market, giving it an atypical profile in a diversified portfolio. The monthly volatility, measured at 9.80, remains contained despite the amplitude of the recent rise.
